When will the Podophyllum Resin Topical Tincture shortage end?

FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.

Does FDA list alternatives to Podophyllum Resin Topical Tincture?

No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.

Is Podophyllum Resin Topical Tincture being discontinued?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

DISCONTINUATION NOTICE

Podophyllum Resin Top…: 1 maker discontinuing

Topical solutions & tinctures

A generic topical solution, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.

DRUG

Podophyllum Resin Topical Tincture

FDA LISTING

Podophyllum Resin Topical Tincture

FORM

topical liquid

STATUS

Discontinuation

FIRST POSTED

Jul 23, 2026

LAST FDA UPDATE

Jul 23, 2026

AS OF

Oct 24, 2026

SOURCE

FDA Drug Shortages ↗ (opens in a new tab)

1 discontinuation notice below, in FDA's words. A discontinuation “does not necessarily create a shortage” (FDA).

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Podophyllum Resin Topical Tincture. 1 presentation from 1 maker.

Check your own medication, form and strength

What to ask at the counter

Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
Is my strength or the maker you stock affected? FDA list, by presentation
Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Discontinuation notices

A discontinuation “does not necessarily create a shortage” (FDA).

Padagis US LLC told FDA it will discontinue Podocon 25 (posted Jul 23, 2026).
“Discontinuation of the manufacture of the drug”
FDA listing: Podophyllum Resin Topical Tincture

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Podophyllum Resin Topical Tincture being discontinued?: As of Oct 24, 2026, FDA lists discontinuation notices for Podophyllum Resin Topical Tincture, not a shortage. A discontinuation “does not necessarily create a shortage” (FDA).
When will the Podophyllum Resin Topical Tincture shortage end?: FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Podophyllum Resin Topical Tincture?: No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.